One Case of Severe Allergic Reactions Caused by Hydrotalcite Chewable Tablets

doi:10.19803/j.1672-8629.20240940

Abstract

Abstract: Objective To explore serious allergic reactions caused by hydrotalcite chewable tablets so as to provide a reference for clinical practice. Methods One case was analyzed in which hydrotalcite chewable tablets were used after surgery to prevent severe allergic reactions caused by digestive tract injury. The mechanism of occurrence, clinical manifestations, and treatment of sub-adverse reactions were investigated based on literature. Results Correlation analysis found that there was a close relationship between the time this adverse reaction occurred and the time of medication. The adverse reaction was classified as a grade II severe allergic reaction. This patient’s symptoms improved after treatment with anti-allergy drugs, blood pressure elevation and rehydration. Conclusion Clinicians should be alert to severe allergic reactions caused by hydrotalcite chewable tablets. The related mechanism remains elusive and more studies are needed.

Key words: Hydrotalcite Chewable Tablets, Anaphylaxis, Adverse Drug Reaction

CLC Number:

R975
R994.11

SHAO Yifan, CHENG Qiucen, ZHAI Huiqi, WU Wei, CHU Qingmin. One Case of Severe Allergic Reactions Caused by Hydrotalcite Chewable Tablets[J]. Chinese Journal of Pharmacovigilance, 2025, 22(9): 1054-1056.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/10.19803/j.1672-8629.20240940

https://zgywjj.magtechjournal.com/EN/Y2025/V22/I9/1054

References

[1] HAO AK.Effectiveness of Magnesium Aluminum Carbonate as an Aid in the Treatment of Gastric Ulcers[J]. Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine(实用中西医结合临床), 2021, 21(24): 132-134.
[2] Chinese Expert Consensus Group on Prevention and Treatment of Digestive Tract Injury by Antiplatelet Drugs. Chinese Expert Consensus on the Prevention and Treatment of Gastrointestinal Tract Injury by Antiplatelet Drugs[J]. Chinese Journal of Internal Medicine(中华内科杂志), 2013, 52(3): 264-270.
[3] Food and Drug Allergy Prevention Group, Specialized Committee on Prevention and Control of Allergic Diseases, Chinese Preventive Medical Association. Chinese Expert Consensus on Drug Allergy Diagnosis and Prevention Programs[J]. Chinese Journal of Preventive Medicine(中华预防医学杂志), 2022, 56(6): 682-706.
[4] LIN TK.Analysis of the Effect and Adverse Reaction of Omeprazole Combined with Magnesium Aluminum Carbonate in the Treatment of Gastric Ulcer with Bleeding[J]. Chinese Journal of Modern Drug Application(中国现代药物应用), 2020, 14(24): 199-201.
[5] WU YN.Study on the Effect and Adverse Reactions of Hydrotalcite Chewable Tablets and Omeprazole in Treating Gastric Ulcer[J]. Fertility & Health(婚育与健康), 2023, 29(11): 85-87.
[6] ZHON XR.A Case Report of Allergic Reaction to Aluminum Hydroxide Gel[J]. Tianjin Medical Journal(天津医药杂志), 1965(2): 121.
[7] YAN XH, JIANG XQ, LI YH.A Case of Generalized Urticaria Due to Allergy to Colloidal Bismuth Pectin Capsule[J]. Chinese Journal of Modern Applied Pharmacy(中国现代应用药学), 2002(3): 204.
[8] Gastrointestinal Hormone and Mucosal Barrier Group, Chinese Society of Gastroenterology, Chinese Medical Association. Consensus of Clinical Experts on Gastrointestinal Mucosal Protection (2021, Fuzhou)[J]. Chinese Journal of Gastroenterology(胃肠病学), 2021, 41(12): 798-811.
[9] World Health Organization.Influenza(seasonal)[EB/OL]. [2024-12-01]. https://www.who.int/en/news-room/fact-sheets/detal/influenza-(seasonal).
[10] XU JM, DAI RP, ZHANG YL, et al.Intra-Hospital Standardization of Perioperative Severe Allergic Reaction Management Process[J]. Central South Pharmacy(中南药学), 2024, 22(4): 831-833.
[11] CARDONA V, ANSOTEGUI IJ, EBISAWA M, et al.World Allergy Organization Anaphylaxis Guidance 2020[J]. World Allergy Organ J, 2020, 13(10): 100472.
[12] YANG J, WANG Y, DENG L, et al.Factors Influencing Medical Staff's Understanding of Correct Use for Adrenaline in the Treatment of Severe Allergic Reactions: a Literature Review[J]. Journal of New Medicine(新医学), 2024, 55(10): 843-847.
[13] GU JQ.Updated Highlights of the 2020 Edition of the Practice Guidelines for Severe Allergic Reactions[J]. Chinese Journal of Allergy & Clinical Immunology(中华临床免疫和变态反应杂志), 2020, 14(5): 505-506.
[14] LI XT, ZHAI SD, WANG Q, et al.Recommendations of the Emergency Guidelines for Severe Allergic Reactions[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2019, 21(2): 85-91.

[1]	JIANG Xiaofeng, YANG Shuting, BAI Liqin, QI Jun, HE Jianxiong, CHEN Wenge, LIANG Zuhong, LI Yu, YU Xiaoxia. Monitoring of Adverse Drug Reactions Caused by Hospital Preparations and Evaluation Systems [J]. Chinese Journal of Pharmacovigilance, 2025, 22(9): 1008-1011.
[2]	CAI Jie, HAN Chenyuan, JIANG Junwei. 887 Reports of Adverse Drug Reactions Induced by Intravenous Drip of Antibacterial Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(9): 1018-1023.
[3]	XIE Jiali, XUN Yan, TAO Yunsong, ZHANG Shengpeng. 211 Reports of Adverse Drug Reactions Induced by New Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(9): 1029-1033.
[4]	LIU Qin, ZHANG Jiayi, WU Xuan, SOANES Nigel. An Automatic Generation Platform for Adverse Drug Reaction Reports from Literature Sources Based on the Generative Artificial Intelligence Large Language Model [J]. Chinese Journal of Pharmacovigilance, 2025, 22(9): 1040-1044.
[5]	LI Shuyue, QIU Huiying, WU Jiaqi, GAO Junwei. Two Cases of Thrombosis Caused by Ethinylestradiol and Cyproterone Acetate Tablets during Thrombocytopenia in Patients with Acute Myeloid Leukemia [J]. Chinese Journal of Pharmacovigilance, 2025, 22(9): 1045-1048.
[6]	LI Dan, YANG Xiongwen, CHEN Danjun, FU Chengxiao, YANG Bo. One Case of Rhabdomyolysis in Patients with Chronic Kidney Disease Caused by Benzafibrate Tablets [J]. Chinese Journal of Pharmacovigilance, 2025, 22(9): 1049-1050.
[7]	QIAN Fengdan, ZHANG Lichao, GONG Yifei. One Case of Severe Anaphylactic Shock Caused by Hemocoagulase Agkistrodon for Injection [J]. Chinese Journal of Pharmacovigilance, 2025, 22(9): 1051-1053.
[8]	WEI Ying, LI Wenfeng, ZHANG Yufei, HOU Xin, YANG Yanwei, FAN Yongli. One Case of Pustular Psoriasis Caused by Duvalumab Injection [J]. Chinese Journal of Pharmacovigilance, 2025, 22(9): 1057-1060.
[9]	LI Mingying, ZHANG Xiaoxia, SUN Xiaoli, ZHAO Yan, HE Miao, LI Yanling, DUAN Wei, YANG Ou. Effect of Sugammadex on Recovery of Patients after Laparoscopic Total Pelvic Floor Reconstruction [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 896-901.
[10]	KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
[11]	LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932.
[12]	ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940.
[13]	ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943.
[14]	CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946.
[15]	YANG Xin, YANG Baochun, YANG Yang, SHAO Huan. One Case of Multiple Endocrine Adverse Effect Caused by Sintilimab [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 947-949.